Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

12.14
Delayed Data
As of Feb 27
 -0.35 / -2.80%
Today’s Change
2.45
Today|||52-Week Range
16.87
-0.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues2.4M247.0K2.6M0.00
 
 
 
 
Cost of Goods Sold2.7M3.1M--0.00
 
 
 
Depreciation And Amortization615.0K327.0K408.0K399.0K
 
 
 
 
 
 
Operating ExpensesGross Income-829.0K-3.2M---399.0K
 
 
 
 
General Expenses24.5M41.2M50.0M59.1M
 
 
 
 
 
Research And Development20.5M35.4M39.6M46.7M
 
 
 
 
 
Total Operating Expenses27.7M44.6M50.5M59.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.3M-44.3M-47.8M-59.5M
 
 
 
 
 
Interest Expense On Debt284.0K45.0K68.0K52.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-25.5M-44.2M-47.7M-58.9M
 
 
 
 
 
Income Taxes0.000.00-554.0K0.00
 
 
Net Income-25.5M-44.2M-47.1M-58.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS45.1M64.2M74.0M94.0M
 
 
 
 
 
Shares To Calculate EPS Diluted45.1M64.2M74.0M94.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.57-$0.69-$0.64-$0.63
 
 
 
 
 
EPS Diluted-$0.57-$0.69-$0.64-$0.63
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account